HL9: 5-[(3~{a}~{S},4~{S},6~{a}~{R})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]-~{N}-(1-pyridin-4-ylpiperidin-4-yl)pentanamide
HL9 is a Ligand Of Interest in 6T2Z designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 6T2Z_HL9_B_201 | 90% | 52% | 0.083 | 0.973 | 0.57 | 1.15 | - | 4 | 0 | 0 | 100% | 1 |
| 6T2Z_HL9_A_201 | 86% | 52% | 0.098 | 0.972 | 0.61 | 1.11 | - | 4 | 0 | 0 | 100% | 1 |
| 6T2L_HL9_A_201 | 100% | 51% | 0.032 | 0.996 | 0.6 | 1.15 | - | 6 | 0 | 0 | 100% | 1 |
| 6T1E_HL9_A_405 | 98% | 36% | 0.05 | 0.987 | 1.14 | 1.27 | 3 | 4 | 0 | 0 | 100% | 1 |
| 6T1K_HL9_A_201 | 96% | 39% | 0.065 | 0.986 | 0.57 | 1.67 | - | 6 | 1 | 0 | 100% | 1 |
| 6T1G_HL9_A_201 | 90% | 27% | 0.072 | 0.96 | 1.05 | 1.77 | 2 | 9 | 0 | 0 | 100% | 1 |
| 6T2Y_HL9_A_302 | 87% | 43% | 0.08 | 0.957 | 0.81 | 1.26 | - | 4 | 0 | 0 | 100% | 1 |
| 6T31_HL9_A_201 | 99% | 54% | 0.042 | 0.991 | 0.5 | 1.1 | - | 2 | 0 | 0 | 100% | 1 |
| 6T32_HL9_A_201 | 96% | 42% | 0.059 | 0.979 | 0.66 | 1.45 | - | 6 | 0 | 0 | 100% | 1 |
